Join Mills & Reeve for this webinar where we will discuss the Medicines and Medical Devices Bill – the UK regulatory environment following Brexit.
As the end of the Brexit transition period approaches we see UK Government making plans to move forward as a standalone regulatory system. A central plank of these plans is the Medicines and Medical Devices Bill. This was published in February, and is making its way through the Parliamentary process. Although existing EU law will be brought over into the UK system from 1 January 2021, the Bill gives broad powers to the Health Minister to develop the law to fit UK priorities. Promoting fast-track approval of innovative medicines and technologies and reducing red tape, as well as promoting UK-based industry, will take on greater importance.
For medical devices, the situation is made more complex by the forthcoming full implementation of the new EU regulations on medical devices and in vitro diagnostics. Likewise, the EU clinical trials system is yet to be rolled out pending completion of the EMA’s new portal and database. The UK will have to decide how closely to track these systems, while, of course, adopting its own administrative structures to implement them.
During this webinar we will review the latest position, and consider likely outcomes for the UK regulatory environment.
There will also be an opportunity to ask the presenters questions.
DURATION: 1 hour
This free to attend event is held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses, the value of which is £190, but is delivered completely free of charge to participants.
Speaker Profiles:
James Fry, Head of Life Sciences and Partner at Mills & Reeve
James heads the firm’s fast growing, multi-disciplinary life sciences practice and focuses exclusively on this sector. The practice supports clients in the pharma and biotech, medical device, diagnostic, medtech and digital health sub-sectors. James’ own practice focuses on intellectual property, commercial contracting and regulatory work.
Isabel Teare, Senior Legal Adviser at Mills & Reeve
Isabel Teare is a Senior Legal Adviser at Mills & Reeve. She started her career in molecular biology, and focuses on all aspects of life sciences law and regulation.
